LIOPENT Trademark

Trademark Overview

On Monday, October 26, 2020, a trademark application was filed for LIOPENT with the United States Patent and Trademark Office. The USPTO has given the LIOPENT trademark a serial number of 90278612. The federal status of this trademark filing is FIFTH EXTENSION - GRANTED as of Tuesday, January 16, 2024. This trademark is owned by Sigmapharm Laboratories, LLC. The LIOPENT trademark is filed in the Pharmaceutical Products category with the following description:

pharmaceutical preparations for thyroid conditions
liopent

General Information

Serial Number90278612
Word MarkLIOPENT
Filing DateMonday, October 26, 2020
Status734 - FIFTH EXTENSION - GRANTED
Status DateTuesday, January 16, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 27, 2021

Trademark Statements

Goods and Servicespharmaceutical preparations for thyroid conditions

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, December 16, 2020
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameSigmapharm Laboratories, LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressBensalem, PA 19020
Party NameSigmapharm Laboratories, LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressBensalem, PA 19020

Trademark Events

Event DateEvent Description
Wednesday, January 17, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, January 16, 2024SOU EXTENSION 5 GRANTED
Friday, December 22, 2023SOU EXTENSION 5 FILED
Tuesday, January 16, 2024CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, December 22, 2023SOU TEAS EXTENSION RECEIVED
Saturday, May 6, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, May 4, 2023SOU EXTENSION 4 GRANTED
Thursday, May 4, 2023SOU EXTENSION 4 FILED
Thursday, May 4, 2023SOU TEAS EXTENSION RECEIVED
Friday, March 31, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, March 31, 2023ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, March 31, 2023TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, November 23, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, November 21, 2022SOU EXTENSION 3 GRANTED
Monday, November 21, 2022SOU EXTENSION 3 FILED
Monday, November 21, 2022SOU TEAS EXTENSION RECEIVED
Thursday, June 16, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, June 14, 2022SOU EXTENSION 2 GRANTED
Tuesday, June 14, 2022SOU EXTENSION 2 FILED
Tuesday, June 14, 2022SOU TEAS EXTENSION RECEIVED
Friday, November 12, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, November 10, 2021SOU EXTENSION 1 GRANTED
Wednesday, November 10, 2021SOU EXTENSION 1 FILED
Wednesday, November 10, 2021SOU TEAS EXTENSION RECEIVED
Tuesday, June 22, 2021NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, April 27, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 27, 2021PUBLISHED FOR OPPOSITION
Wednesday, April 7, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, March 25, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, March 25, 2021ASSIGNED TO EXAMINER
Wednesday, December 16, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, October 29, 2020NEW APPLICATION ENTERED

Related Keywords

liopent conditions thyroid preparations pharmaceutical